X4 Pharmaceuticals earnings were -$99.7M for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. The latest XFOR earnings report on Mar 31, 2026 announced Q1 2026 earnings of -$20.2M, down 15.4% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, XFOR reported annual earnings of -$79.2M, with 111.5% growth. The next XFOR earnings date is Aug 14, 2026.
What were X4 Pharmaceuticals's earnings last quarter?
X4 Pharmaceuticals (NASDAQ: XFOR) reported Q1 2026 earnings per share (EPS) of -$0.16, up 500% year over year. Total XFOR earnings for the quarter were -$20.24 million. In the same quarter last year, X4 Pharmaceuticals's earnings per share (EPS) was $0.04.
The next XFOR earnings call is Aug 14, 2026. Add XFOR to your watchlist to be reminded of X4 Pharmaceuticals's next earnings date.
Is X4 Pharmaceuticals profitable or losing money?
As of the last X4 Pharmaceuticals earnings report, X4 Pharmaceuticals is currently losing money. X4 Pharmaceuticals's net profit (also called net income) for the twelve months ending Mar 31, 2026 was -$99.72 million, a 783.12% decrease year over year.
What was XFOR's earnings growth in the past year?
As of X4 Pharmaceuticals's earnings date in Q3 2026, X4 Pharmaceuticals's earnings has grown year over year. XFOR earnings in the past year totalled -$99.72 million.
What are X4 Pharmaceuticals's earnings expectations?
The current EPS estimate for X4 Pharmaceuticals's earnings report in Aug 14, 2026 is -$0.19.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.